1. Home
  2. ALDX vs CCIR Comparison

ALDX vs CCIR Comparison

Compare ALDX & CCIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • CCIR
  • Stock Information
  • Founded
  • ALDX 2004
  • CCIR 2021
  • Country
  • ALDX United States
  • CCIR United States
  • Employees
  • ALDX N/A
  • CCIR N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • CCIR
  • Sector
  • ALDX Health Care
  • CCIR
  • Exchange
  • ALDX Nasdaq
  • CCIR NYSE
  • Market Cap
  • ALDX 398.3M
  • CCIR 351.0M
  • IPO Year
  • ALDX 2014
  • CCIR 2024
  • Fundamental
  • Price
  • ALDX $2.12
  • CCIR $11.26
  • Analyst Decision
  • ALDX Strong Buy
  • CCIR
  • Analyst Count
  • ALDX 3
  • CCIR 0
  • Target Price
  • ALDX $9.67
  • CCIR N/A
  • AVG Volume (30 Days)
  • ALDX 3.3M
  • CCIR 502.1K
  • Earning Date
  • ALDX 05-01-2025
  • CCIR 01-01-0001
  • Dividend Yield
  • ALDX N/A
  • CCIR N/A
  • EPS Growth
  • ALDX N/A
  • CCIR N/A
  • EPS
  • ALDX N/A
  • CCIR 0.16
  • Revenue
  • ALDX N/A
  • CCIR N/A
  • Revenue This Year
  • ALDX N/A
  • CCIR N/A
  • Revenue Next Year
  • ALDX N/A
  • CCIR N/A
  • P/E Ratio
  • ALDX N/A
  • CCIR $68.04
  • Revenue Growth
  • ALDX N/A
  • CCIR N/A
  • 52 Week Low
  • ALDX $1.14
  • CCIR $9.92
  • 52 Week High
  • ALDX $7.20
  • CCIR $12.80
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 26.33
  • CCIR N/A
  • Support Level
  • ALDX $1.79
  • CCIR N/A
  • Resistance Level
  • ALDX $2.32
  • CCIR N/A
  • Average True Range (ATR)
  • ALDX 0.49
  • CCIR 0.00
  • MACD
  • ALDX -0.32
  • CCIR 0.00
  • Stochastic Oscillator
  • ALDX 17.53
  • CCIR 0.00

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About CCIR COHEN CIRCLE ACQUISITION CORP I

Cohen Circle Acquisition Corp I is a blank check company.

Share on Social Networks: